Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (476)	5/19/2001 11:55:55 AM
From: scaram(o)uche	Respond to of 2243

Weekday Trader May 17, 2001 Some Pros Like Biotech at Current Prices By Evelyn Ellison Twitchell Y ou can clobber the Nasdaq. You can squash semiconductor stocks. And you can outright murder Internet shares. But biotechnology just keeps bouncing back. (snip) public.wsj.com

To: scaram(o)uche who wrote (476)	5/19/2001 12:02:50 PM
From: tuck	Read Replies (1) \| Respond to of 2243

Rick, Hope you have a good time out in Nevada; best to you and yours. >>$15.5K, burning a hole in "2000"'s pocket. Warning..... I may spend it on KDUS if someone doesn't speak up!<< Well, I was thinking of adding on further weakness. Say, below .8. You could do a lot worse. Trickle feels AGNT, MCLS, PBSC, DPII, and perhaps EBIO, are all undervalued, but probably won't provide the instant gratification of a DCGN. Nigel's been watching the price to cash ratios while I've been watching lock-up expiration dates, so we're catching different stuff. >>my unread pile for Trickle is at 45 posts<< An executive Trickle summary for busy biofreaks . . . Trickle has spent considerable time listening to conference calls in the wake of ABI's warning, which was founded on slowing sales of industrial strength sequencers (Ditto MDCC). Trickle has found that R&D budgets are changing, not shrinking, reflecting the shift from industrial genomics towards proteomics. Some trickle companies -- especially those not in consumables and proteomics related instrumentation -- are seeing delays in orders. Trickle says buy the consumables and LC/MS companies (sample prep -- fractionating and digesting equipment, should also do well) on weakness. Trickle has no immediate suggestions, as Trickle has been expecting a pullback for the last week, and still does. Cheers, Tuck